Brain disorders pose a significant global health challenge that demands a strong, united response. To tell us what a unified framework that supports an integrated approach to mental and neurological health looks like, we reached out to the European Brain Council (EBC), a network of key stakeholders in the field of brain health.
As artificial intelligence (AI) and brain technologies develop at a breathtaking speed, scientists are warning that one of the oldest and most important questions in science remains unanswered: what is consciousness?
Breakthrough research shows the brain doesn't drift into sleep gradually; it hits a sudden "tipping point." Discover how scientists pinpoint the second your brain shuts down each night.
Although age is a risk factor, there are other modifiable factors that can influence dementia risk and disease progression. Angela Bradshaw, the Director for Research at Alzheimer Europe, emphasises the need for more comprehensive interventions across multiple areas to support dementia prevention
UCL researchers have developed an ultrasound helmet that enables deep brain stimulation without surgery, offering hope for Parkinson's and other neurological disorders.
NIH researchers found that the brain's control centre for a lost limb persists long after amputation, challenging theories of cortical remapping. This insight into phantom limb syndrome could inform future neuroprosthetic and pain treatments.
Stanford researchers have created a brain-computer interface that translates imagined speech into text, enabling communication for individuals with severe paralysis.
Researchers using patient-derived stem cells reveal a rare ALS mutation triggers a chronic stress response in motor neurons, blocking it reverses damage in lab models, paving the way for new treatment strategies.
Johns Hopkins researchers have grown a multi-region human brain organoid with rudimentary blood vessels and connected neural circuits that mimic fetal brain development.
New research from the University of Nottingham shows the COVID-19 pandemic may have accelerated brain ageing by over five months, even in people who were never infected, due to stress and lifestyle changes.
A major £40 million investment will drive pioneering research at the University of Edinburgh, aiming to transform diagnosis and treatment for conditions such as autism, fragile X syndrome, and ADHD.
UCL and UCLH launch the Win‑Glio trial led by Dr Paul Mulholland, offering ipilimumab immunotherapy to newly diagnosed glioblastoma patients ahead of standard treatment.
The University of Liverpool is leading a £2.7 million clinical trial to investigate vagus nerve stimulation as a treatment for people with drug-resistant epilepsy.
